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Abstract
Purpose The purpose of this study was to describe the pre-
scription of antibacterial agents for acute upper respiratory
tract infections (URIs) in Beijing.
Methods A total of 8,588,699 outpatient cases in tertiary hos-
pitals with acute upper respiratory tract infections (URIs) were
selected from the Beijing Medical Claim Data for Employees
(BMCDE) from Oct 2010 to Sep 2012. Second-generation
cephalosporins, third-generation cephalosporins, fourth-
generation cephalosporins, fluoroquinolones, macrolides (ex-
cept for erythromycin), combinations of penicillins (including
β-lactamase inhibitors), and streptomycins were classified as
broad-spectrum antibacterial agents. The rates for antibiotic
prescriptions and broad-spectrum antibiotic use were calculat-
ed in all cases as well as in various URI diagnosis subgroups
and age (18–44, 45–64, and ≥65 years) subgroups. The most
frequently prescribed antibiotic classes were identified by cal-
culating the proportions of the different agents in all pre-
scribed antibiotic agents.
Results Overall, the rate of antibiotic prescription is 39.0 %,
and cases diagnosed with acute tonsillitis, sinusitis, and
epiglottitis have the highest prescription rate (73.6 %),
followed by acute laryngitis and bronchitis (52.3 %), acute
pharyngitis (40.1 %), and acute nasopharyngitis (37.2 %).
Broad-spectrum agents were chosen in 82.4 % of the cases
that were prescribed antibiotics, ranging from 81.9 % of cases
with naspharyngitis to 87.1 % of the cases with tonsillitis,
sinusitis, and epiglottitis. Second-generation cephalosporins,
macrolides, fluoroquinolones, third-generation cephalospo-
rins, and combinations of penicillins were most frequently
prescribed, accounting for more than 80 % of all prescribed
antibacterials.
Conclusions Antibacterial drug prescription for outpatients
with acute URIs is common in tertiary hospitals in Beijing,
and the prescribed antibacterials are usually broad-spectrum
agents.
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Introduction
Acute upper respiratory tract infections (URIs) are the most
common infectious illnesses in the general population, and
they are the leading cause of missed days at work or school.
They represent the most frequent acute diagnosis in the office
setting [1]. Acute URIs include the common cold, laryngitis,
pharyngitis, tonsillitis, sinusitis, and epiglottitis, and the
symptoms commonly include runny nose, cough, sore throat,
nasal congestion, headache, low-grade fever, sneezing, and
malaise. URIs are largely self-limiting, and the majority of
these infections are viral and have no cure [2]. Although the
available evidence has shown that antibiotics probably pro-
vide little benefit for a large proportion of respiratory tract
infections, antibiotics are still largely inappropriately used in
clinics [3]. Extensive data have shown that there is excessive
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antibiotic prescription and overuse of newer broad-spectrum
antibiotics for acute URIs in many regions [4–7].
Overprescription of antibiotics is costly, exposes patients to
potential side effects and is a major contributor to emerging
antibiotic resistance [8–10]. In Europe and the USA, efforts
utilizing public health campaigns [11], provider education,
and practice guidelines [12] have attempted to reduce antibi-
otic use with varying degrees of success [7, 13, 14]. In China,
increasing attention in recent years has been focused on the
misuse of antibiotics, and regulations for proper antibiotic use
have been established. However, a basic profile for antibiotic
use is limited. In this study, we will describe the prescription
of antibacterial agents for outpatients with acute URIs in ter-
tiary hospitals in Beijing.
Methods
Data source
Beijing Medical Claim Data for Employees (BMCDE) were
used, which contain medical claim data for all working or
retired employees who are covered by basic medical insurance
in Beijing. Anonymized information on the patient demo-
graphic characteristics (age and sex), clinical diagnosis, med-
ications, and reimbursement information were included. Clin-
ical diagnoses were presented in the forms of the International
Classification of Disease edition 10 (ICD-10) as well as de-
scriptive texts. Details on the dispensed medications consisted
of the branded and generic drug names, formulations, fees,
and dispensing date. Ethical approval is not required for the
use of encrypted retrospective information.
Study population
Outpatient cases who were diagnosed with acute URIs in ter-
tiary hospitals were included in the analysis.
The inclusion criteria were the following: (1) outpatient
visits in tertiary hospitals; (2) age≥18 years; (3) diagnoses
of acute nasopharyngitis (common cold) (ICD-10J00), acute
sinusitis (ICD-10J01), acute pharyngitis (ICD-10 J02), acute
tonsillitis (ICD-10J03), acute laryngitis and tracheitis (ICD-
10J04), acute obstructive laryngitis and epiglottitis (ICD-
10J05), acute upper respiratory infections of multiple and un-
specified sites (ICD-10J06); (4) complete medication records;
and (5) visits between October 1, 2010 and September 30,
2012.
The exclusion criteria were the following: (1) doubtful
cases of acute URIs, such as Bfever of unknown origin^ or
Bacute tonsillitis to be confirmed^ and (2) follow-up visits
within 1 month of a prior visit.
Drug classification
Antibacterial agents were sorted according to the Anatomical
Therapeutic Chemical (ATC) classification system (WHO,
version 2015 [15]). Second-generation cephalosporins
(J01DC), third-generation cephalosporins (J01DD), fourth-
generation cephalosporins (J01DE), fluoroquinolones
(J01MA), macrolides (J01FA, except for erythromycin
J01FA01), combinations of penicillins (including β-
lactamase inhibitors (J01CR)), and streptomycins (J01GA)
were classified as broad-spectrum antibacterial agents. All
other antibiotics were classified as narrow-spectrum, mainly
including erythromycin (J01FA01), penicillins with extended
spectrum (J01CA), first-generation cephalosporins (J01DB),
and other antibacterials.
Analysis
The baseline demographic characteristics are shown as the
means (and standard deviations) for continuous variables
and as the numbers (and percentages) for categorical mea-
sures. The rates for antibiotic prescriptions were calculated
as cases prescribed with one or more antibacterial agents di-
vided by all cases. The broad-spectrum antibiotic use propor-
tions were calculated as the percentage of cases prescribed
with broad-spectrum antibacterial agents divided by the cases
prescribed with all types of antibacterial agents. All of the
above results were calculated in all cases as well as in the
various URI diagnosis subgroups and age (18–44, 45–64,
and ≥65 years) subgroups. Cases with acute tonsillitis, sinus-
itis, and epiglottitis were combined in one subgroup due to the
small sample sizes. The most frequently prescribed antibiotic
classes were identified by calculating the proportions of the
different agents of all antibiotic agents that were used. All of
the analyses were performed using the Statistical Analysis
System software, version 8.2 (SAS Institute, Cary, NC, USA).
Results
Basic characteristics
8,588,699 cases with acute URIs were selected in this study.
The mean age was 57.6 ± 14.7 years; 19.0 % were 18 to
44 years old, 49.3 % were 45 to 64 years old, and 31.7 %were
65 years and above. Male cases accounted for 39.4 % of total
cases. Most of the cases (81.9 %) were diagnosed with acute
nasopharyngitis (common cold or acute upper respiratory in-
fections of multiple and unspecified sites). Details of the age,
sex distribution, and disease classification of the cases are
shown in Table 1.
A more detailed description of the study population is giv-
en in the supplementary materials.
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Antibiotic prescription rate
Of all cases, 3,347,423 cases received antibacterial agents
with an antibiotic prescription rate of 39.0%. Cases with acute
tonsillitis, sinusitis, and epiglottitis had the highest antibiotic
prescription rates (73.6 %), which was followed by acute lar-
yngitis and bronchitis (52.3 %), acute pharyngitis (40.1 %),
and acute nasopharyngitis (37.2 %). The rate of antibiotic
prescriptions was 34.0 % for the cases aged 65 years and
older, and this was lower than rates in the cases who were
45 to 64 years of age (38.5 %) and 18 to 44 years of age
(48.5 %). For all URI diagnosis subgroups, the rates of anti-
biotic prescriptions in the 18–44 years of age subgroup were
all higher than rates in the older groups, as seen in Fig. 1. The
rates of antibiotic prescriptions in the male and female cases
were 73.2 % and 69.7 %, respectively. More men received
antibiotic treatment than women (Fig. 1).
Broad-spectrum antibiotic use
Broad-spectrum antibiotics were commonly prescribed, but
they varied across age and diagnosis subgroups. Broad-
spectrum agents were chosen in 82.4 % of the cases that were
prescribed antibiotics, ranging from 81.9 % of the cases with
nasopharyngitis to 87.1 % of cases with tonsillitis, sinusitis,
and epiglottitis. For all diagnostic subgroups, the proportion
of broad-spectrum antibiotics used in cases 18–44 years of age
was the highest, while the proportion in cases older than
64 years of age was the lowest. The proportion of broad-
spectrum antibiotic use in men was higher than in women
(Table 2).
Categories of antibacterial agents
For cases in which antibacterial agents were prescribed,
91.0 % received a single antibacterial agent, whereas the
remainder of cases received two or more kinds of antibacterial
agents. Among all categories of antibiotics, second-generation
cephalosporins (J01DC) are the most commonly used, ac-
counting for 32.8 %. These are followed by macrolides
(J01FA, accounting for 18.7 %), fluoroquinolones (J01MA,
accounting for 15.4 %), third-generation cephalosporins
(J01DD, accounting for 9.0 %), and combinations of penicil-
lins (J01CR, accounting for 6.4 %), as illustrated in Table 3.
With respect to second-generation cephalosporins, the
most commonly used antibiotics were cefuroxime and
cefaclor. With respect to third-generation cephalosporins, the
most commonly used antibiotics were cefdinir and cefixime.
The most commonly used fluoroquinolone was levofloxacin.
The most commonly used macrolides were azithromycin and
erythromycin (Table 3).
Discussion
Although substantial research suggests that antibiotics proba-
bly provide little benefit for a large proportion of respiratory
tract infections, the results of this study show that nearly 40 %
of outpatients with acute URIs received antibacterial drug pre-
scriptions in tertiary hospitals in Beijing. Antibacterial drug
prescriptions are common in tertiary hospitals in Beijing for
cases with acute URIs, which is similar to results in the USA
[13, 16] and some European countries [17]. In 2011, the Eu-
ropean Surveillance of Antimicrobial Consumption project
(ESAC) published a set of relevant evidence-based disease-
specific quality indicators for outpatient antibiotic use. The
acceptable range for the percentage of adult patients with
acute URIs who were prescribed antibacterials is 0–20 %
[18]. The total prescription rates of antibiotics in this study
were much higher than the threshold recommended by the
ESAC. The study results also show that different types of
URIs have different antibacterial prescription rates. Cases of
Table 1 Basic characteristics of
the cases with acute URIs 18–44 years 45–64 years 65–years Total
N % N % N % N %
Gender
Male 594,487 36.4 1,439,734 34.0 1,353,244 49.8 3,387,465 39.4




1,276,584 78.3 3,493,597 82.4 2,262,610 83.2 7,032,791 81.9
Acute pharyngitis 226,329 13.9 449,971 10.6 241,207 8.9 917,507 10.7
Acute laryngitis and
bronchitis
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acute tonsillitis, sinusitis, and epiglottitis had the highest rate
of antibacterial prescription (73.6 %), whereas cases with
acute nasopharyngitis had the lowest rate (37.2 %). In these
data, even the lowest antibiotic prescription rate for acute
nasopharyngitis is almost two times the ESAC threshold. In
this study, there were different antibiotic prescription rates
across age and sex subgroups. Females and older cases with
URIs had lower rates than males and young adult cases. These
results are similar to other studies [13, 16].
The current study results implicate that antibacterials for
URIs in tertiary hospitals in Beijing are usually broad-spec-
trum, new generation agents. According to the ESAC quality
indicators, extended spectrum penicillins and β-lactamase-
sensitive penicillins should account for 80–100 % antibiotic
prescriptions, and quinolones for no more than 5 % [18]. In
this study, penicillins with extended spectrum and β-
lactamase-sensitive penicillins accounted for only about
3.4 %, while fluoroquinolones accounted for approximately
15 %, which is threefold higher than the recommendation.
Broad-spectrum agents accounting for about 80 % of all pre-
scribed antibacterials. The constitution of antibacterials in this
study is largely different from the ESAC recommendations,
and it is also different from the antibacterials that are used in
the USA and Europe. In the United States, doxycycline,
macrolides, and fluoroquinolones have a prominent position
as first-line agents for the outpatient treatment of respiratory
tract infections, whereas patients in Europe generally receive
β-lactam agents [17]. The differences between the antibacte-
rials used in different regions may be related to the different
clinically relevant infections, patients’ and physician’s
choices, commercial pressures, and differences in regulation.
Cephalosporins are not the first-line drugs for respiratory
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Fig. 1 Antibiotic prescription rates for cases with acute URIs
Table 2 Proportion of broad-
spectrum antibiotic use in the
cases using antibiotics
Gender Diagnosis 18–44 years 45–64 years 65 years Total
Male
Acute tonsillitis, sinusitis, and epiglottitis 88.4 86.5 86.2 87.3
Acute laryngitis and bronchitis 88.9 87.0 86.0 86.9
Acute nasopharyngitis 85.5 82.5 81.1 82.7
Acute pharyngitis 83.8 82.7 81.3 82.6
All URIs 85.6 83.0 81.7 83.1
Female
Acute tonsillitis, sinusitis, and epiglottitis 88.2 86.2 84.9 87.0
Acute laryngitis and bronchitis 88.3 86.2 85.1 86.3
Acute nasopharyngitis 84.5 81.1 79.0 81.4
Acute pharyngitis 83.3 81.4 79.9 81.7
All URIs 84.7 81.6 79.8 82.0
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infections, while in this study, approximately 40 % of the
cases received second- and third-generation cephalosporins.
This is similar to other studies, wherein the use of newer
broad-spectrum cephalosporins in the USA and many Euro-
pean countries has increased to a level of inappropriate use
[17, 19].
There are limitations in this study. First, only the primary
diagnosis was examined in these data. When we performed
the analysis, antibiotic prescriptions were attributed to the first
diagnosis, while antibiotics might also have been prescribed
for the second or third diagnosis, especially for those with
other infectious comorbidities. This might have resulted in
misclassification, potentially over-representing the frequency
of antibiotic prescription for URIs. Second, because our data
did not capture the dose for each prescription, we were unable
to assess antibiotic consumption in quantity, which could oth-
erwise provide more precise information on the prescribing of
antibiotic agents. Third, the patient population in this sample
is not representative of all acute URIs, limiting the generaliz-
ability. Patients in the BMCDE data only include working or
retired employees and residents who are covered by medical
insurance; unemployed residents with no medical insurance
are not represented in this population. When using these re-
sults, caution should be exercised.
Although there are limitations, to the best of our knowl-
edge, this is the first study that uses administrative data to
describe the use of antibacterial agents for acute URIs in Bei-
jing. According to these results, antibacterial drug
prescriptions for outpatients with acute URIs are common in
tertiary hospitals in Beijing, and the most commonly pre-
scribed antibacterials are mostly broad-spectrum agents. Be-
cause antimicrobial resistance is a major global public health
problem and antibiotic consumption is increasingly recog-
nized as the main reason for resistance [8, 9], judicious anti-
biotic prescription is critical for preserving antibiotic effec-
tiveness. Public health officials, providers, and policymakers
should lead the efforts to promote appropriate antibiotic use.
Many European Union countries impose policy restrictions or
perform national awareness campaigns to decrease inappro-
priate antibiotic prescription [17, 20]. Antibacterial consump-
tion has decreased in some of these countries [7]. Reductions
in the US antibiotic prescription rates have been observed
since the launch of the Centers for Disease Control and Pre-
vention’s BGet Smart: Know When Antibiotics Work^ cam-
paign [14]. These successful experiences should be adapted to
improve the antibiotic use in China. Further studies on anti-
bacterial prescriptions in primary health care settings, among
emergency patients and inpatients, antibiotic consumption
doses, and factors associated with antibiotic consumptions in
China are needed.
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